However, concern remains that pioglitazone may increase the risk for heart failure (HF) in susceptible individuals.The 5-year HF risk did not differ by treatment (4.1% pioglitazone, 4.2% placebo). Risk for hospitalized HF was low and not significantly greater in pioglitazone compared with placebo...